Literature DB >> 32638115

Clinical evaluation of an in-house-developed real-time RT-PCR assay for serotyping of dengue virus.

M B Kakade1, N Shrivastava1, J A Patil1, D Parashar1, P S Shah1, K Alagarasu2.   

Abstract

In the present study, an in-house-developed real-time RT-PCR (rRT-PCR) for serotyping of dengue virus (DENV) was evaluated for its performance, using 612 clinical samples. Compared to the composite reference standard, the in-house-developed rRT-PCR had an overall sensitivity of 97.5% and a specificity of 100%. The assay had a sensitivity of 100%, 95.6%. 96.9% and 100% for detecting DENV-1, DENV-2, DENV-3 and DENV-4, respectively. We recommend periodic evaluation of real-time RT-PCR assays for detecting DENV serotypes with a large number of samples and the use of at least two assays that target different regions of DENV genomes.

Entities:  

Year:  2020        PMID: 32638115     DOI: 10.1007/s00705-020-04725-0

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  1 in total

1.  Use of whole blood over plasma enhances the detection of dengue virus RNA: possible utility in dengue vaccine trials.

Authors:  K Alagarasu; M B Kakade; R V Bachal; M Bote; D Parashar; P S Shah
Journal:  Arch Virol       Date:  2020-11-27       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.